These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 3733887)

  • 1. Receptor occupancy by a bovine sialoglycopeptide inhibitor correlates with inhibition of protein synthesis.
    Bascom CC; Sharifi BG; Johnson TC
    J Cell Physiol; 1986 Aug; 128(2):202-8. PubMed ID: 3733887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of epidermal growth factor-stimulated DNA synthesis by a bovine sialoglycopeptide inhibitor occurs at an intracellular level.
    Bascom CC; Sharifi BG; Johnson TC
    J Cell Biochem; 1987 Aug; 34(4):283-91. PubMed ID: 3497936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of gangliosides in the interaction of a growth inhibitor with mouse LM cells.
    Bascom CC; Sharifi BG; Melkerson LJ; Rintoul DA; Johnson TC
    J Cell Physiol; 1985 Dec; 125(3):427-35. PubMed ID: 4066767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between protease activity and a sialoglycopeptide inhibitor isolated from bovine brain.
    Sharifi BG; Bascom CC; Fattaey H; Nash S; Johnson TC
    J Cell Biochem; 1986; 31(1):41-57. PubMed ID: 3522610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell surface interaction is sufficient for the biological activity of a bovine sialoglycopeptide inhibitor.
    Sharifi BG; Bascom CC; Johnson TC
    Biochem Biophys Res Commun; 1986 Feb; 134(3):1350-7. PubMed ID: 3947369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the retinoblastoma protein in cell cycle arrest mediated by a novel cell surface proliferation inhibitor.
    Enebo DJ; Fattaey HK; Moos PJ; Johnson TC
    J Cell Biochem; 1994 Jun; 55(2):200-8. PubMed ID: 8089195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of DNA synthesis and cell division by a cell surface sialoglycopeptide.
    Fattaey H; Johnson TC; Chou HH
    J Cell Physiol; 1989 May; 139(2):269-74. PubMed ID: 2715187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protamine inhibits platelet derived growth factor receptor activity but not epidermal growth factor activity.
    Huang JS; Nishimura J; Huang SS; Deuel TF
    J Cell Biochem; 1984; 26(4):205-20. PubMed ID: 6099364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of calcium in growth inhibition induced by a novel cell surface sialoglycopeptide.
    Betz NA; Westhoff BA; Johnson TC
    J Cell Physiol; 1995 Jul; 164(1):35-46. PubMed ID: 7790395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of a calcium and a sodium ionophore on protein synthesis inhibition by a bovine cell surface sialoglycopeptide.
    Sharifi BG; Bascom CC; Johnson TC
    Biochem Biophys Res Commun; 1986 May; 136(3):976-82. PubMed ID: 3087351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle variation in 125I-labeled epidermal growth factor binding in chemically transformed cells.
    Robinson RA; Branum EL; Volkenant ME; Moses HL
    Cancer Res; 1982 Jul; 42(7):2633-8. PubMed ID: 6979383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin receptor synthesis and turnover in differentiating 3T3-L1 preadipocytes.
    Lane MD; Reed BC; Clements PR
    Prog Clin Biol Res; 1981; 66 Pt A():523-42. PubMed ID: 6171829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium influences sensitivity to growth inhibition induced by a cell surface sialoglycopeptide.
    Betz NA; Fattaey HK; Johnson TC
    J Cell Physiol; 1994 Dec; 161(3):553-61. PubMed ID: 7962136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell agglutination by a novel cell surface sialoglycopeptide inhibitor and the relationship between its protease and biological activities.
    Sobieski RJ; Johnson TC; Sharifi BG; Bascom CC
    Life Sci; 1986 May; 38(20):1883-8. PubMed ID: 3517541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a sialoglycopeptide on early events associated with signal transduction.
    Toole-Simms WE; Loder DK; Fattaey HK; Johnson TC
    J Cell Physiol; 1991 May; 147(2):292-7. PubMed ID: 2040660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The angiogenesis inhibitor SU5416 has long-lasting effects on vascular endothelial growth factor receptor phosphorylation and function.
    Mendel DB; Schreck RE; West DC; Li G; Strawn LM; Tanciongco SS; Vasile S; Shawver LK; Cherrington JM
    Clin Cancer Res; 2000 Dec; 6(12):4848-58. PubMed ID: 11156244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concanavalin A induced apoptosis in fibroblasts: the role of cell surface carbohydrates in lectin mediated cytotoxicity.
    Kulkarni GV; McCulloch CA
    J Cell Physiol; 1995 Oct; 165(1):119-33. PubMed ID: 7559793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716.
    Major TC; Keiser JA
    J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fc receptors of a human promyelocytic leukemic cell line: evidence for two types of receptors defined by binding of the staphylococcal protein A-IgG1 complex.
    Crabtree GR
    J Immunol; 1980 Jul; 125(1):448-53. PubMed ID: 6991603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth inhibition of BALB/c mouse keratinocytes by TGF-beta 1 and CeReS-18 appears to act through distinct mechanisms.
    Betz NA; Fattaey HK; Johnson TC
    Exp Cell Res; 1996 Aug; 227(1):47-54. PubMed ID: 8806450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.